ScholarIQanswers from OpenAlex & ORCID
Kelly S. Oliner
ResearcherPublications, citations & collaboration network
Kelly S. Oliner is a researcher indexed in ScholarIQ from OpenAlex & ORCID.
How many works does Kelly S. Oliner have?
ScholarIQindexed works
Kelly S. Oliner has 151 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Kelly S. Oliner have?
ScholarIQcitation count
Kelly S. Oliner has 16,654 citations in the OpenAlex counts ScholarIQ stores.
What is the h-index of Kelly S. Oliner?
ScholarIQh-index
Kelly S. Oliner has an h-index of 33 in OpenAlex.
What is the i10-index of Kelly S. Oliner?
ScholarIQi10-index
Kelly S. Oliner has an i10-index of 49 in OpenAlex.
What is the OpenAlex record for Kelly S. Oliner?
ScholarIQopenalex
The OpenAlex for Kelly S. Oliner is on the source record.
What are the most-cited papers on Kelly S. Oliner?
ScholarIQmost cited works
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Chetan Bettegowda, Mark Sausen, Rebecca Leary, Isaac Kinde, Yuxuan Wang, Nishant Agrawal, Bjarne R. Bartlett, Hao Wang, Brandon Luber, Rhoda M. Alani, Emmanuel S. Antonarakis, Nilofer S. Azad, Alberto Bardelli, Henry Brem, John L. Cameron, Clarence Lee, Leslie A. Fecher, Gary L. Gallia, Peter Gibbs, Dung T. Le, Robert Giuntoli, Michael Goggins, Michael D. Hogarty, Matthias Holdhoff, Seung‐Mo Hong, Yuchen Jiao, Hartmut Juhl, Jaeyeon Kim, Giulia Siravegna, Daniel A. Laheru, Calogero Lauricella, Michael Lim, Evan J. Lipson, Suely Kazue Nagahashi Marie, George J. Netto, Kelly S. Oliner, Alessandro Olivi, Louise Olsson, Gregory J. Riggins, Andrea Sartore‐Bianchi, Kerstin Schmidt, le-Ming Shih, Sueli Mieko Oba‐Shinjo, Salvatore Siena, Dan Theodorescu, Jeanne Tie, Timothy T. Harkins, Silvio Veronese, Tian‐Li Wang, Jon Weingart, Christopher L. Wolfgang, Laura D. Wood, Dongmei Xing, Ralph H. Hruban, Jian Wu, Peter J. Allen, C. Max Schmidt, Michael A. Choti, Victor E. Velculescu, Kenneth W. Kinzler, Bert Vogelstein, Nickolas Papadopoulos, Luis A. Díaz
Final results from PRIME: randomized phase III study of panitumumab with FOLFOX4 for first-line treatment of metastatic colorectal cancer
J.-Y. Douillard, Salvatore Siena, J Cassidy, Josep Tabernero, Ronald L. Burkes, Mario Barugel, Yves Humblet, G. Bodoky, David Cunningham, Jacek Jassem, Fernando Rivera, Ilona Kocáková, Paul Ruff, Maria Błasińska-Morawiec, Martin Šmakal, J.-L. Canon, M. Rother, Kelly S. Oliner, Ying Tian, Feng Xu, R. Sidhu